Ropivacaine hydrochloride
USP/1605500 - United States Pharmacopeia (USP) Reference Standard
Synonym: Ropivacaine hydrochloride monohydrate; (2S)
CAS Number: 132112-35-7
Empirical Formula (Hill Notation): C17H26N2O · HCl · H2O
Molecular Weight: 328.88
MDL Number: MFCD00946578
Linear Formula: C17H26N2O · HCl · H2O
Product Type: Chemical
API family | ropivacaine |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C17H26N2O.ClH.H2O/c1-4 |
InChI key | VSHFRHVKMYGBJL-CKUXDGONSA |
manufacturer/tradename | USP |
SMILES string | O.Cl.CCCN1CCCC[C@H]1C(=O) |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Ropivacaine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
Biochem/physiol Actions: | Local anaesthetic with less cardiotoxicity than bupivacaine; causes reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the cell membrane of the nerve fibers. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS05 |
Signal word | Danger |
Hazard statements | H318 |
Precautionary statements | P280 - P305 + P351 + P338 + P310 |
RIDADR | UN 2811 6.1 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |